Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received...

Prof Thomas Powles - Barts Cancer Institute, London, England

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab ( Prof Thomas Powles - Barts Cancer Institute, London, England )

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours...

Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery ( Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA )

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid...

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics...

Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )

Metastasis-directed radiotherapy shows good prognosis for oligometastatic...

Dr Chad Tang - MD Anderson Cancer Center, Houston, USA

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer ( Dr Chad Tang - MD Anderson Cancer Center, Houston, USA )

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair...

Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York...

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours ( Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma

Dr Milad Ibrahim - NYU Langone Health, New York, USA

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma ( Dr Milad Ibrahim - NYU Langone Health, New York, USA )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA...

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos

The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible...

Dr Sarah Psutka - University of Washington, Seattle, USA

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy ( Dr Sarah Psutka - University of Washington, Seattle, USA )

More from ecancer